← Back to Search

Peer Comparison Feedback for High Blood Pressure

N/A

Waitlist Available

Led By Shivan Mehta, MD,MBA,MSHP

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will compare whether monthly peer comparison messages to primary care providers will increase provider engagement with patients' overall hypertension management.

Who is the study for?

This trial is for Primary Care Providers at Penn Medicine Lancaster with at least 30 patients who have high blood pressure. These patients must be aged 18-85 and have had a diagnosis of hypertension in the last two years. Excluded are providers with fewer than 30 such patients, those caring for patients with end stage renal disease, recent pregnancy, or indicators of end-of-life care.Check my eligibility

What is being tested?

The study tests if sending monthly peer comparison messages to doctors can improve how they manage high blood pressure. It looks at whether these messages encourage doctors to start or increase doses of blood pressure medications among their patients.See study design

What are the potential side effects?

Since this trial involves communication strategies rather than medical treatments, there are no direct side effects related to drugs or interventions typically associated with clinical trials.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in new hypertensive medication prescriptions or an increased dose of hypertensive medication

Secondary outcome measures

Change in hypertension control percentage

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

This group will receive peer comparison messages.

Group II: ControlActive Control1 Intervention

This group will not receive peer comparison messages and will continue with usual care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,882,190 Total Patients Enrolled

Shivan Mehta, MD,MBA,MSHPPrincipal InvestigatorUniversity of Pennsylvania

1 Previous Clinical Trials

80,215 Total Patients Enrolled

Media Library

Peer Comparison Message Clinical Trial Eligibility Overview. Trial Name: NCT05160012 — N/A

High Blood Pressure Research Study Groups: Control, Intervention

High Blood Pressure Clinical Trial 2023: Peer Comparison Message Highlights & Side Effects. Trial Name: NCT05160012 — N/A

Peer Comparison Message 2023 Treatment Timeline for Medical Study. Trial Name: NCT05160012 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor still open to enrollment?

"The trial data on clinicaltrials.gov indicates that this study is not currently recruiting participants. The protocol was initially posted April 5th 2022 and the last edit occurred November 1st 2022. Though this particular medical research project has concluded its patient recruitment, there are 746 other trials in need of volunteers right now."

Answered by AI

Who is eligible to partake in this experiment?

"Recruitment is underway for this trial, which requires participants to have hypertension and fall between 18-85 years of age. A total of 93 test subjects are needed to take part in the study."

Answered by AI